Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
作者信息
Brand Rachel
出版信息
State Legis. 2008 Sep;34(8):26-9.
PMID:18754159
Abstract
摘要
相似文献
1
2
Pharmaceutical industry influences on physician prescribing: gifts, quasi-gifts, and patient-directed gifts.制药行业对医生处方的影响：礼物、准礼物和面向患者的礼物。
Am J Bioeth. 2003 Summer;3(3):56-7. doi: 10.1162/15265160360706615.
3
Contact with pharmaceutical representatives: where does prudence lead?与医药代表接触：审慎会指向何方？
Am J Bioeth. 2010 Jan;10(1):11-3. doi: 10.1080/15265160903441046.
4
5
Response to open peer commentaries on "The pitfalls of deducing ethics from economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing".对关于“从经济学推导伦理学的陷阱：为何美国医学院协会在医药推广方面的观点是错误的”的公开同行评论的回应
Am J Bioeth. 2010 Jan;10(1):W1-3. doi: 10.1080/15265160903493088.
6
Drug detailers, professionalism, and prudence.药品推销员、专业素养与审慎态度。
Am J Bioeth. 2010 Jan;10(1):9-10. doi: 10.1080/15265160903441020.
7
The devil in the detail(ing).细节决定成败。
Am J Bioeth. 2010 Jan;10(1):15-7. doi: 10.1080/15265160903460905.
8
The pitfalls of misreading: what does "industry funding of medical education" actually say?误读的陷阱：“医学教育的行业资助”究竟意味着什么？
Am J Bioeth. 2010 Jan;10(1):24-5. doi: 10.1080/15265160903441038.
9
The invisible influence of industry inducements.行业诱导的无形影响。
Am J Bioeth. 2003 Summer;3(3):65-7. doi: 10.1162/15265160360706679.
10
Both sides of pharmaceutical promotion.药品推广的两面性
Adv Nurse Pract. 2007 Jan;15(1):61-2, 64-5, 74.
引用本文的文献
1
Growth hormone and health policy.生长激素与卫生政策。
J Clin Endocrinol Metab. 2010 Jul;95(7):3149-53. doi: 10.1210/jc.2009-2688. Epub 2010 Apr 28.
Zotero 插件